Integral Health Asset Management »

Prothena shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Prothena (PRTA) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Prothena

Tip: Access up to 7 years of quarterly data

All positions including Prothena held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prothena by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $3.6M 52k 68.28

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Prothena

FMR
BlackRock
Vanguard Group
Armistice Capital
Rubric Capital Management
ADAR1 Capital Management
Palo Alto Investors
D. E. Shaw & Co
Susquehanna International
Acadian Asset Management
Geode Capital Management
Citadel Advisors
State Street Corporation
Jane Street
Jacobs Levy Equity Management

View all funds holding Prothena